The Kerala High Court recently issued a significant ruling regarding the government's authority to intervene in the pharmaceutical market. The court affirmed that the Centre possesses the power under the Patents Act to manufacture patented life-saving drugs and provide them to patients at lower costs. This legal interpretation is intended to assist individuals who are unable to afford expensive treatments due to current market pricing.

The case originated from a petition filed by a cancer patient seeking access to affordable medication. However, the patient died before the court could hear the case, highlighting the lengthy nature of the legal process in such matters. While the court has now clarified the government's power to act, the ruling serves as a posthumous resolution to the petitioner's request. The decision establishes a legal precedent that could influence how the government manages drug accessibility in the future, particularly for life-threatening conditions where patented drugs remain prohibitively expensive for the average citizen.